Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The company is evaluating spevatamig in Phase II clinical studies for various ga...
With this validation, the agency will begin its formal assessment of the applica...
The platform enables pharmaceutical companies to deploy AI agents across clinic...
IPC 2026 will focus on transforming India from the Pharmacy of the World to a P...
The approval covers Pitolisant Tablets 4.45 mg and 17.8 mg, bioequivalent to Wa...
The facility received 11 observations during the USFDA inspection conducted fro...
State and UT Drugs Controllers asked to identify manufacturers, marketers, dist...
LSSSDC Skillverse 2026 will focus on workforce requirements, Industry 5.0, Glob...
The combination is intended for patients who have previously received at least o...
The collaboration aims to develop new quantum algorithms that could accelerate t...
Platform brings regulatory intelligence, labelling, gap assessments, health aut...
Triggered by recent high profile operations involving counterfeit semaglutide i...
St. Luke’s University Health Network is preparing to open a new heart hospital a...
HMC Architects is expanding its healthcare practice into the Pacific Northwest w...
Momentum’s Beehive acoustic wall panel is designed to provide sound absorption w...
The decision marks the third NMPA-approved indication for an ivonescimab-contain...